share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

艾伯維公司 | 4:持股變動聲明-董事 Alpern Robert J
美股SEC公告 ·  07/02 16:49
Moomoo AI 已提取核心訊息
In a recent transaction dated 06/30/2024, Robert J Alpern engaged in a stock market activity involving shares of AbbVie Inc. [ABBV]. The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed. Consequently, the number of shares held by Alpern after the transaction remains unknown. This event may be of interest to investors monitoring insider activities within AbbVie Inc.
In a recent transaction dated 06/30/2024, Robert J Alpern engaged in a stock market activity involving shares of AbbVie Inc. [ABBV]. The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed. Consequently, the number of shares held by Alpern after the transaction remains unknown. This event may be of interest to investors monitoring insider activities within AbbVie Inc.
最近一次交易日爲06/30/2024,Robert J Alpern參與了AbbVie股份公司[ABBV]的股票市場活動。交易的具體細節,包括交易的股票數量,股份的性質,交易價格和股份的總價值,均未披露。因此,交易後Alpern所持有的股份數量仍然未知。這一事件可能會引起投資者對AbbVie Inc.內部交易的關注。
最近一次交易日爲06/30/2024,Robert J Alpern參與了AbbVie股份公司[ABBV]的股票市場活動。交易的具體細節,包括交易的股票數量,股份的性質,交易價格和股份的總價值,均未披露。因此,交易後Alpern所持有的股份數量仍然未知。這一事件可能會引起投資者對AbbVie Inc.內部交易的關注。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息